GlobeStar Therapeutics Co. (OTCMKTS:GSTC) Sees Significant Increase in Short Interest

GlobeStar Therapeutics Co. (OTCMKTS:GSTC) was the target of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 336,400 shares, a growth of 146.1% from the October 15th total of 136,700 shares. Based on an average daily volume of 14,596,100 shares, the days-to-cover ratio is currently 0.0 days.

GlobeStar Therapeutics Stock Performance

GlobeStar Therapeutics stock opened at $0.00 on Friday. GlobeStar Therapeutics has a fifty-two week low of $0.00 and a fifty-two week high of $0.00.

GlobeStar Therapeutics Company Profile

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc and changed its name to GlobeStar Therapeutics Corporation in July 2021.